T1000	Speculation 2285 2299	indicates that
E1000	Speculation:T1000 Scope:T1001
T1001	Span 2285 2377	indicates that the induction of IL10 is a general property associated with enhanced survival
T1002	Negation 2173 2175	no
E1001	Negation:T1002 Scope:T1003
T1003	Span 2173 2258	no correlation between the levels of LMP1 expression and the levels of IL10 induction
T1004	Negation 2459 2462	not
E1002	Negation:T1004 Scope:T1005
T1005	Span 2459 2531	not affect the survival of lymphoma cells as determined by the MTS assay
T1006	Speculation 2382 2385	may
E1003	Speculation:T1006 Scope:T1007
T1007	Span 2382 2421	may only be indirectly affected by LMP1
T1008	Speculation 2902 2917	indicating that
E1004	Speculation:T1008 Scope:T1009
T1009	Span 2902 2977	indicating that lymphoma cells are responsive to IL10 treatment (Figure 5C)
T1010	Speculation 2552 2562	suggesting
E1005	Speculation:T1010 Scope:T1011
T1011	Span 2552 2595	suggesting constitutive activation of Stat3
T1012	Negation 3359 3362	not
E1006	Negation:T1012 Scope:T1013
T1013	Span 3340 3441	nuclear pStat3 was not detected by immunohistochemistry staining of spleen sections from control mice
T1014	Speculation 3062 3065	may
E1007	Speculation:T1014 Scope:T1015
T1015	Span 3062 3103	may be further enhanced by IL10 induction
T1016	Speculation 3673 3681	suggests
E1008	Speculation:T1016 Scope:T1017
T1017	Span 3673 3752	suggests that Stat3 signaling contributes to LMP1-mediated lymphoma development
T1018	Negation 326 336	Expression
E1009	Negation:T1018 Scope:T1019
T1019	Span 326 435	Expression levels were quantified with a phosphorimager and normalized to the ribosomal housekeeping gene L32
T1020	Speculation 84 87	may
E1010	Speculation:T1020 Scope:T1021
T1021	Span 84 148	may contribute to the increased survival and growth of lymphomas
T1022	Negation 1030 1033	not
E1011	Negation:T1022 Scope:T1023
T1023	Span 1030 1076	not a unique property of malignant lymphocytes
T1024	Negation 799 801	no
E1012	Negation:T1024 Scope:T1025
T1025	Span 799 918	no significant difference in the expression of IL15 and IFNgamma between LMP1 transgenic lymphocytes and lymphoma cells
T1026	Speculation 1656 1670	indicated that
E1013	Speculation:T1026 Scope:T1027
T1027	Span 1656 1886	indicated that LMP1 transgenic lymphocytes and wild-type and LMP1 transgenic lymphoma cells had corresponding increased levels of phosphorylated alpha and beta isoforms of activated Stat3, a target of the IL10 receptor (Figure 5B)
T1028	Speculation 920 930	suggesting
E1014	Speculation:T1028 Scope:T1029
T1029	Span 920 1076	suggesting that upregulation of IL15 and IFNgamma is induced by LMP1 expression in healthy lymphocytes but is not a unique property of malignant lymphocytes
T1030	Negation 2076 2079	not
E1015	Negation:T1030 Scope:T1031
T1031	Span 2049 2147	the activation of Stat3 is not solely induced by IL10 or that Stat3 activation may be constitutive
T1032	Negation 1942 1944	no
E1016	Negation:T1032 Scope:T1033
T1033	Span 1942 2028	no correlation between the levels of IL10 induction and the levels of Stat3 activation
T1034	Speculation 2128 2131	may
E1017	Speculation:T1034 Scope:T1035
T1035	Span 2128 2147	may be constitutive
T1036	Speculation 2035 2043	suggests
E1018	Speculation:T1036 Scope:T1037
T1037	Span 2035 2102	suggests that the activation of Stat3 is not solely induced by IL10
